
French Tech 2030
Lancé en partenariat avec le Secrétariat général pour l’investissement et Bpifrance, le programme French Tech 2030 accompagne pendant deux ans les acteurs émergents qui répondent à de grands enjeux de société, selon les priorités stratégiques du plan France 2030. Les 125 entreprises sélectionnées bénéficient d’un accompagnement financier et extra-financier, coordonné par la Mission French Tech.
French Tech 2030

Amolyt Pharma
Advancing peptides for the treatment of rare endocrine and related diseases Amolyt Pharma is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma’s portfolio includes eneboparatide (AZP-3601), a long-acting PTH1 receptor agonist as a potential treatment for hypoparathyroidism, … [voir plus]

Astraveus
We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. [voir plus]

DNA Script
Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s … [voir plus]

Enterome
Delivering the promise of immunotherapy Enterome is a clinical-stage biopharmaceutical company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases. Enterome’s pioneering approach to drug discovery is based on its unique and powerful bacterial Mimicry drug discovery platform, which allows it to analyze and uncover new biological … [voir plus]

Fabentech
Fabentech is a privately owned biopharmaceutical SME based in Lyon (France) and created in 2009, which develops immunotherapies to address situations of emergency. In an environment where the globalization of trade accelerates the spread of epidemics and where the geopolitical context increases the risk of bioterrorist attacks, nations should be … [voir plus]

Faircraft
Faircraft develops a highly sustainable, lab-grown alternative to animal leather. Faircraft develops a highly sustainable, lab-grown alternative to animal leather, based on advanced tissue engineering and material science techniques. [voir plus]

GAIAGO
Nous croyons que l'Homme est vivant quand la Terre est vivante. Nous revitalisons les sols en restaurant et renforçant l’équilibre minéral et biologique des sols. Nous agissons sur la fertilité naturelle des sols et la nutrition des plantes pour une triple performance agronomique, économique et écologique. Nous développons, fabriquons et … [voir plus]

Green Spot Technologies
Challenging the food waste paradigm to feed a better future ✨FoodTech 500 ✨Earthshot Prize ✨French Tech 2030 Green Spot Technologies (GST) utilise sa technologie de fermentation en milieu solide et l'upcycling pour proposer les ingrédients alimentaires de demain. 1/ Gamme de solutions alternatives d'ingrédients cacao Ferment'Up, des poudres permettant de … [voir plus]

ImCheck Therapeutics
Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic ImCheck Therapeutics is designing and developing a new generation of immunotherapeutic antibodies targeting butyrophilins, a novel super-family of immunomodulators. As demonstrated by lead clinical-stage program ICT01, which has a mechanism of action to simultaneously modulate innate and adaptive immunity, … [voir plus]

Kiro
L'intelligence artificielle au service de la biologie médicale Kiro est une startup en pleine croissance qui développe des solutions d’intelligence artificielle pour la biologie médicale. Nous cherchons à améliorer l'expérience du parcours de soins en fournissant des informations plus compréhensibles aux patients et plus pertinentes aux médecins. Nous pensons que … [voir plus]

Osivax
Pioneering A New Class of Universal Vaccines Osivax is a clinical-stage biopharmaceutical company leveraging its novel, self-assembling nanoparticle platform technology, oligoDOM, to develop transformative, first-in-class pan-respiratory virus vaccines generating superior T-cell responses in addition to strong and sustained B-cell responses. The company is establishing proof of concept with its broad-spectrum, … [voir plus]

Qubit Pharmaceuticals
Anything is Druggable - with Quantum Accuracy Qubit Pharmaceuticals brings unparalleled accuracy and precision to drug discovery and design, using quantum physics to develop life-changing treatments for major diseases. We leverage our technologies and expertise to advance 7 fully owned drug discovery programs focusing on cancer resistance and escapement, a … [voir plus]

TreeFrog Therapeutics
Cell Therapy for All TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant … [voir plus]

Woodoo
Augmented wood / Decarbonized materials for a new industrial revolution. Woodoo is unlocking the future of construction—leading the way toward more sustainable, resilient cities. How? By transforming underutilized hardwood into a cutting-edge wood composite material: STACK. STACK redefines what wood can do, providing a low-carbon and high-performance alternative to steel, … [voir plus]

Ÿnsect
The world leader in insect ingredient production: a natural, healthy and sustainable solution to feed the world. Ÿnsect is one of world leader in the production of protein and natural insect fertilizers. Founded in 2011 in Paris, France, by both scientists and environmental activists, the company processes insects into high-end, … [voir plus]

Generare
Natural molecule discovery, industrialized Natural products have contributed more than 500 molecules to pharmaceuticals. However, conventional methods for discovering new natural products are increasingly ineffective. Generare has developed a revolutionary platform that identifies and expresses a wide range of naturally occurring secondary metabolites, selected by millions of years of bacterial … [voir plus]

iktos
Artificial intelligence for new drug design We are a leader in artificial intelligence and robotic solutions applied to research in medicinal chemistry and new drug design. Iktos' proprietary and innovative generative AI solution enables the design of molecules that are optimized in silico to meet all the success criteria of … [voir plus]

TheraPanacea
Empowering Artificial Intelligence towards Precision Medicine TheraPanacea is an innovative information technology company devoted to unlocking the power of AI-based solutions to drive innovation in healthcare. A spin-off of University Paris-Saclay, TheraPanacea works in close cooperation with the most prominent healthcare facilities to combine the power of its proprietary platforms … [voir plus]

TiHive
Terahertz vision and AI for efficient industries. Terahertz-AI Vision company, disrupting industrial process and quality monitoring for a more sustainable and efficient industry. We are an imaging and sensing company providing Terahertz and Artificial Intelligence solutions for industrial quality and process control, sensing, and communications. We are proud to serve … [voir plus]